We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SMBC:NASDAQSouthern Missouri Bancorp, Inc. Analysis

Data as of 2026-05-26 - not real-time

$68.99

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Southern Missouri Bancorp (SMBC) is trading at $68.99, comfortably above its 20‑day (68.38) and 50‑day (66.16) moving averages, confirming a bullish price trend despite a bearish MACD histogram. The RSI of 57.8 indicates the stock is not overbought, while the 30‑day volatility of 20.5% and a beta of 0.86 suggest moderate price swings with lower market sensitivity. Fundamentals reinforce the technical picture: a forward PE of 10.2 versus the industry average of 16.8, a price‑to‑book of 1.35, and a dividend yield of 1.45% with a modest payout ratio of 16% highlight attractive valuation and sustainable income. Revenue grew 6.5% year‑over‑year to $185.7 M, and the bank posted a strong operating margin of 48% and ROE of 12%, underscoring robust profitability. Recent quarterly results show net interest income up $3.7 M and the declaration of a $0.25 per share dividend, providing short‑term catalyst momentum. Analyst coverage is limited (three analysts) with a median price target of $73, implying roughly 6% upside from current levels.
However, the regional banking sector faces headwinds, and decreasing trading volume points to a potential liquidity drag, which tempers enthusiasm. The DCF‑derived fair value of $96.8 suggests deeper long‑term upside, but the more conservative consensus target keeps expectations modest. Liquidity risk remains medium as volume trends downward, but the company’s solid cash position of $93.8 M provides a cushion. Overall, SMBC appears undervalued relative to peers, offers a stable dividend, and maintains solid capital metrics, making it a compelling buy for medium‑ to long‑term investors while a hold stance is prudent in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above 20‑day and 50‑day SMAs indicating bullish trend
  • Bearish MACD histogram and decreasing volume suggest caution
  • Upcoming ex‑dividend and quarterly dividend payout

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to industry PE and fair‑value DCF estimate
  • Strong profitability metrics (ROE 12%, operating margin 48%)
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term upside potential shown by DCF fair value of $96.8
  • Consistent earnings growth and solid cash position
  • Stable regional presence with low geographic and currency risk

Key Metrics & Analysis

Financial Health

Revenue Growth6.50%
Profit Margin36.26%
P/E Ratio11.5
ROE12.22%
ROA1.33%
P/B Ratio1.4
Op. Cash Flow$93.9M
Industry P/E16.8

Technical Analysis

TrendBullish
RSI57.8
Support$66.09
Resistance$70.10
MA 20$68.38
MA 50$66.16
MA 200$59.84
MACDBearish
VolumeDecreasing
Fear & Greed Index91.71

Valuation

Fair Value$96.83
Target Price$73.33
Upside/Downside6.30%
GradeUndervalued
TypeValue
Dividend Yield1.45%

Risk Assessment

Beta0.86
Volatility20.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.